Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1

  • Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) Packages (Simulation)
  • Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) Packages (Simulation)
  • RPA794Ra01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

USAGE of the Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Rattus norvegicus (Rat) Applications (RESEARCH USE ONLY!)
RPA794Ra01 Recombinant Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) Positive Control; Immunogen; SDS-PAGE; WB.
PAA794Ra01 Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) WB; IHC; ICC; IP.
GUESTBOOK